Insider · CIK 0001767584
Hongbo Lu
Files at ARWR (ARROWHEAD PHARMACEUTICALS, INC.), TERN (Terns Pharmaceuticals, Inc.), ZBIO (Zenas BioPharma, Inc.). First filing Oct 9, 2025, latest Mar 31, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZBIO: Zenas BioPharma, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 67Notable | Zenas BioPharma, Inc. | $1.5M 75,000 shares | +22% | +189% from low-55% from high | |
| 60Notable | Zenas BioPharma, Inc. | $585k 25,985 shares | +8% | +262% from low-46% from high | |
| 58Moderate | ZBIObuy Zenas BioPharma, Inc. | $6.0M 321,983 shares | - | 0% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | ZBIO Zenas BioPharma, Inc. | POpen-market purchase Common Stockindirect: See footnote | +75,000 | $20.00 | $1.5M | 422,968 | Mar 31, 2026 |
| Feb 11, 2026 | ZBIO Zenas BioPharma, Inc. | POpen-market purchase Common Stockindirect: See footnote | +25,985 | $22.50 | $585k | 347,968 | Feb 13, 2026 |
| Dec 16, 2025 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +7,819 | $0.00 | $0 | 54,982 | Dec 18, 2025 |
| Sep 13, 2024 | ZBIO Zenas BioPharma, Inc. | POpen-market purchase Common Stockindirect: See footnote | +58,823 | $17.00 | $1000k | 58,823 | Oct 9, 2025 |
| Oct 7, 2025 | ZBIO Zenas BioPharma, Inc. | POpen-market purchase Common Stockindirect: See footnote | +263,160 | $19.00 | $5.0M | 321,983 | Oct 9, 2025 |
| Jun 11, 2025 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jun 12, 2025 |
| Jun 10, 2025 | ZBIO Zenas BioPharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,500 | $0.00 | $0 | 18,500 | Jun 12, 2025 |
| Dec 18, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +16,733 | $22.99 | $385k | 47,163 | Dec 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.